Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
Robert F. Kennedy Jr. has big plans for the FDA if he's confirmed as Secretary of Health and Human Services. FDA Commissioner Robert Califf explains why certain changes may not be that easy — or ...
Califf spoke to a group of reporters last week on his last day in the FDA’s White Oak campus in Silver Spring, Md. Here’s his advice to those who will take over public health roles in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results